Statistics for From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease
Total visits
views | |
---|---|
From bench to bedside: preclinical evaluation of a self-inactivating gammaretroviral vector for the gene therapy of X-linked chronic granulomatous disease | 259 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
humc.2013.019.pdf | 322 |
Top country views
views | |
---|---|
United States | 132 |
Germany | 96 |
Ukraine | 5 |
China | 4 |
Canada | 3 |
United Kingdom | 3 |
Singapore | 2 |
Croatia | 1 |
Malaysia | 1 |
Russia | 1 |
Top city views
views | |
---|---|
Wilmington | 56 |
Kiez | 50 |
Gunzenhausen | 36 |
Kansas City | 21 |
Fairfield | 13 |
Nürnberg | 6 |
Jacksonville | 5 |
Kiev | 5 |
Cambridge | 4 |
Houston | 4 |
Netze | 4 |
Chicago | 3 |
Dearborn | 3 |
San Francisco | 3 |
Toronto | 3 |
Ann Arbor | 2 |
Lake Mary | 2 |
Singapore | 2 |
Beijing | 1 |
Brooklyn | 1 |
Hefei | 1 |
Moscow | 1 |
Scottsdale | 1 |
Seremban | 1 |
White Plains | 1 |
Zagreb | 1 |